SCHEMBL20338192

SCHEMBL20338192

CCOC(=O)c1c(Cl)nnc2c1CCCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
MAPT P10636 4/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
LMNA P02545 1/20 0.44
ACHE P22303 12/20 0.43
CACNB4 O00305 5/20 0.43
CACNA1A O00555 5/20 0.43
CACNA1G O43497 5/20 0.43
CACNG3 O60359 5/20 0.43
CACNA1F O60840 5/20 0.43
CACNA1H O95180 5/20 0.43
CACNB3 P54284 5/20 0.43
CACNA2D1 P54289 5/20 0.43
CACNG7 P62955 5/20 0.43
CACNA1B Q00975 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30310866 1.00 KDM4E (0.46) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL30076551 0.97 MAPT (0.44) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL20338237 0.97 MAPT (0.44) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL20338372 0.84 LMNA (0.48) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL30310768 0.84 LMNA (0.48) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL30076558 0.81 MAPT (0.45) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL20338270 0.81 MAPT (0.45) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL7382700 0.79 ACHE (0.43) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL6501518 0.79 ACHE (0.48) KDM4EMAPTALDH1A1GAAHPGD
SCHEMBL7386394 0.78 ACHE (0.44) KDM4EMAPTALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260097034-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LTD (HK) 2026-04-09 US disclosed
US-12458642-B2 Metalloenzyme inhibitor compounds CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2025-11-04 US disclosed
EP-4311577-A2 METALLOENZYME INHIBITOR COMPOUNDS Ji Xing Pharmaceuticals Hong Kong Limited (HK) 2024-01-31 EP disclosed
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
US-20230192617-A1 AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2023-06-22 US disclosed
EP-4153566-A1 AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS Bayer CropScience Aktiengesellschaft (DE) 2023-03-29 EP disclosed
CN-115803317-A Azabicyclo (thio) amides as fungicidal compounds 拜耳作物科学股份公司 2023-03-14 CN disclosed
WO-2021233861-A1 AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2021-11-25 WO disclosed
US-20210322409-A1 METALLOENZYME INHIBITOR COMPOUNDS SELENITY THERAPEUTICS (BERMUDA), LTD. (BM) 2021-10-21 US disclosed
US-11040034-B2 Metalloenzyme inhibitor compounds PHASEBIO PHARMACEUTICALS, INC. (US) 2021-06-22 US disclosed
CN-110691598-A Metalloenzyme inhibitor compounds 赛列尼蒂治疗(百慕大)有限公司 2020-01-14 CN disclosed
EP-3562487-A2 METALLOENZYME INHIBITOR COMPOUNDS Selenity Therapeutics (Bermuda), Ltd. (BM) 2019-11-06 EP disclosed
US-20190008861-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2019-01-10 US disclosed
US-10085984-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-10-02 US disclosed
US-20180185362-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2018-07-05 US disclosed
US-20180185362-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2018-07-05 US disclosed
US-20180185362-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2018-07-05 US disclosed
WO-2018125800-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 WO disclosed
WO-2018125800-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12458642-B2 Metalloenzyme inhibitor compounds CYP11B2, CYP11B1, HSD11B2 KDM4E 2641/4885MAPT 2593/4885ALDH1A1 232/4885
US-20180185362-A1 METALLOENZYME INHIBITOR COMPOUNDS SOD1, RNASE1, FECH KDM4E 3875/4885MAPT 2388/4885ALDH1A1 457/4885
US-20260097034-A1 METALLOENZYME INHIBITOR COMPOUNDS CPN1, TPP1, DPP4 KDM4E 1581/4885MAPT 2173/4885ALDH1A1 189/4885
US-20230192617-A1 AZABICYCLIC(THIO)AMIDES AS FUNGICIDAL COMPOUNDS TPMT, TST, NANP KDM4E 899/4885MAPT 2136/4885ALDH1A1 1003/4885
US-20210322409-A1 METALLOENZYME INHIBITOR COMPOUNDS SOD1, RNASE1, FECH KDM4E 3875/4885MAPT 2388/4885ALDH1A1 457/4885
US-11040034-B2 Metalloenzyme inhibitor compounds SOD1, RNASE1, FECH KDM4E 3875/4885MAPT 2388/4885ALDH1A1 457/4885
US-20190008861-A1 METALLOENZYME INHIBITOR COMPOUNDS SOD1, RNASE1, FECH KDM4E 3875/4885MAPT 2388/4885ALDH1A1 457/4885
US-10085984-B2 Metalloenzyme inhibitor compounds SOD1, RNASE1, FECH KDM4E 3875/4885MAPT 2388/4885ALDH1A1 457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.